| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 22.50▲ | 22.37▲ | 22.23▲ | 21.18▲ | N/A |
| MA10 | 22.16▲ | 21.68▲ | 21.47▲ | N/A | N/A |
| MA20 | 21.50▲ | 21.33▲ | 21.17▲ | N/A | N/A |
| MA50 | 21.10▲ | 20.31▲ | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | N/A | N/A | N/A | N/A | N/A |
| STOCH | 98.868▲ | 99.474▲ | 86.464▲ | N/A | N/A |
| WILL %R | -2.703▲ | -2.083▲ | -2.083▲ | N/A | N/A |
| CCI | 77.582 | 107.550▲ | 120.811▲ | N/A | N/A |
|
Monday, July 15, 2019 04:49 AM
Akero Therapeutics (NASDAQ:AKRO) initiated with Buy rating and $28 (41% upside) price target at Jefferies. Shares down a fraction premarket. Atreca (NASDAQ:BCEL) initiated with Buy rating and $23 ...
|
|
Monday, July 01, 2019 05:00 PM
SAN FRANCISCO, July 2, 2019 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing transformational treatments for patients with non-alcoholic ...
|
|
Monday, June 24, 2019 05:00 PM
SAN FRANCISCO, June 24, 2019 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing transformational treatments for people with non-alcoholic ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/07/19 | 20.53 | 22.735 | 19.72 | 22.38 | 77,367 |
| 19/07/19 | 20.55 | 22.906 | 19.58 | 20.78 | 34,967 |
| 18/07/19 | 21.26 | 21.54 | 20.425 | 20.64 | 72,207 |
| 17/07/19 | 19.65 | 21.27 | 19.55 | 21.27 | 132,576 |
| 16/07/19 | 20.54 | 20.98 | 20.54 | 20.81 | 70,574 |
| 15/07/19 | 20.40 | 20.67 | 19.925 | 20.51 | 59,610 |
| 12/07/19 | 18.26 | 19.29 | 18.155 | 19.29 | 60,526 |
| 11/07/19 | 17.04 | 18.71 | 16.15 | 18.00 | 149,409 |
| 10/07/19 | 17.49 | 17.49 | 16.149 | 16.89 | 80,373 |
|
|
||||
|
|
||||
|
|